Recently Viewed
Clear AllValue Research Rating
Quality Score 
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Market cap
₹63,843 Cr
Revenue (TTM)
₹8,770 Cr
Net Profit (TTM)
₹960 Cr
ROE
9.8 %
ROCE
12.1 %
P/E Ratio
66.5
P/B Ratio
6.6
Industry P/E
44.5
EV/EBITDA
32.2
Div. Yield
0.1 %
Debt to Equity
0.2
Book Value
₹127.5
EPS
₹13.4
Face value
10
Shares outstanding
754,958,148
CFO
₹6,344.19 Cr
EBITDA
₹7,095.09 Cr
Net Profit
₹2,273.72 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Fortis Healthcare
| -4.3 | -6.7 | -2.9 | 41.4 | 47.6 | 35.6 | 16.7 |
|
BSE Healthcare
| -1.7 | -1.1 | -1.9 | 7.5 | 25.6 | 15.6 | 10.7 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Fortis Healthcare
| 24.8 | 63.8 | 46.5 | -3.8 | 90.6 | 16.7 | -5.9 |
|
BSE Mid Cap
| 1.1 | 25.8 | 45.5 | 1.4 | 39.2 | 19.9 | -3.0 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Fortis Healthcare
|
846.0 | 63,843.0 | 8,770.4 | 966.3 | 17.8 | 11 | 66.5 | 6.6 |
| 7,471.0 | 1,07,392.0 | 24,215.2 | 1,820.5 | 11.0 | 21 | 59.6 | 11.2 | |
| 662.0 | 34,286.7 | 4,461.2 | 397.5 | 13.4 | 9.1 | 104.9 | 7.5 | |
| 434.0 | 13,736.8 | 1,976.2 | 160.7 | 14.1 | 6.7 | 109 | 7.0 | |
| 570.0 | 8,470.7 | 2,478.2 | 24.7 | 8.4 | 4.2 | 447 | 6.3 | |
| 1,282.0 | 8,393.4 | 1,433.4 | 188.7 | 17.4 | 13.8 | 44.5 | 5.6 | |
| 979.8 | 95,318.6 | 8,140.3 | 1,419.2 | 21.2 | 15 | 67.2 | 9.2 | |
| 1,690.0 | 34,538.0 | 6,777.7 | 782.9 | 16.1 | 21.5 | 44.3 | 8.2 | |
| 1,123.9 | 11,410.7 | 1,613.3 | 259.9 | 23.0 | 17.3 | 44.3 | 7.2 | |
| 673.3 | 6,489.5 | 1,089.4 | 165.1 | 17.4 | 10.2 | 38.8 | 3.7 |
3 min read•By Value Research
1 min read•By Research Desk
2 min read•By Value Research
2 min read•By Value Research
1 min read•By Research Desk
3 min read•By Research Desk
Fortis Healthcare Limited, an integrated healthcare delivery service provider, offers secondary, tertiary, and quaternary care in India. The company offers services in the areas of cardiac science, cosmetology, dental science, dermatology,... diabetology/endocrinology, emergency and trauma, ENT, foetal medicine, gastroenterology and hepatology science, general surgery, haematology, infertility medicine, internal medicine, mental health and behavioral science, nephrology, neuro surgery, neurointerventional radiology, neurology, obstetrics and gynaecology, oncology, ophthalmology, orthopedics, pediatrics, physiotherapy and rehabilitation, plastic and reconstructive surgery, pulmonology, radiology, organ transplanrheumatology, thoracic surgery, transplantation medicine, urology, and other support specialties, as well as ear, nose, and throat. Its healthcare verticals comprise hospitals, diagnostics, and day care specialty facilities. Fortis Healthcare Limited was founded in 1995 and is based in Gurugram, India. Read more
Incorporated
1996
Chairman
Leo Puri
Managing Director
Ashutosh Raghuvanshi
Group
Fortis
Headquarters
Mohali, Punjab
Website
Looking for more details about Fortis Healthcare Ltd.’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
The share price of Fortis Healthcare Ltd is ₹846.00 (NSE) and ₹845.65 (BSE) as of 18-Mar-2026 IST. Fortis Healthcare Ltd has given a return of 47.63% in the last 3 years.
The P/E ratio of Fortis Healthcare Ltd is 66.52 times as on 18-Mar-2026, a 49 premium to its peers’ median range of 44.50 times.
The P/B ratio of Fortis Healthcare Ltd is 6.63 times as on 18-Mar-2026, a 0 premium to its peers’ median range of 6.63 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
68.11
|
5.92
|
|
2024
|
52.93
|
4.14
|
|
2023
|
33.33
|
2.71
|
|
2022
|
39.49
|
3.55
|
|
2021
|
0.00
|
2.46
|
The 52-week high and low of Fortis Healthcare Ltd are Rs 1,104.30 and Rs 595.80 as of 19-Mar-2026.
Fortis Healthcare Ltd has a market capitalisation of ₹ 63,843 Cr as on 18-Mar-2026. As per SEBI classification, it is a Mid Cap company.
Before investing in Fortis Healthcare Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
₹25.80
(
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.